These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33980885)

  • 1. Functional display of bioactive peptides on the vGFP scaffold.
    Chee SMQ; Wongsantichon J; Yi LS; Sana B; Frosi Y; Robinson RC; Ghadessy FJ
    Sci Rep; 2021 May; 11(1):10127. PubMed ID: 33980885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorescent protein scaffold for presenting structurally constrained peptides provides an effective screening system to identify high affinity target-binding peptides.
    Kadonosono T; Yabe E; Furuta T; Yamano A; Tsubaki T; Sekine T; Kuchimaru T; Sakurai M; Kizaka-Kondoh S
    PLoS One; 2014; 9(8):e103397. PubMed ID: 25084350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2.
    Chee SM; Wongsantichon J; Soo Tng Q; Robinson R; Joseph TL; Verma C; Lane DP; Brown CJ; Ghadessy FJ
    PLoS One; 2014; 9(8):e104914. PubMed ID: 25115702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.
    Burch L; Shimizu H; Smith A; Patterson C; Hupp TR
    J Mol Biol; 2004 Mar; 337(1):129-45. PubMed ID: 15001357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.
    Pazgier M; Liu M; Zou G; Yuan W; Li C; Li C; Li J; Monbo J; Zella D; Tarasov SG; Lu W
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4665-70. PubMed ID: 19255450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization and targeted disruption of protein interactions in living cells.
    Herce HD; Deng W; Helma J; Leonhardt H; Cardoso MC
    Nat Commun; 2013; 4():2660. PubMed ID: 24154492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Shin JS; Ha JH; Chi SW
    Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of ubiquitin-based binder with an inserted active peptide.
    Miyafusa T; Hirota K; Honda S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):3162-3166. PubMed ID: 30146256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide grafting.
    Brown CJ; Dastidar SG; See HY; Coomber DW; Ortiz-Lombardía M; Verma C; Lane DP
    J Mol Biol; 2010 Jan; 395(4):871-83. PubMed ID: 19895821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
    Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
    Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.
    Czarna A; Popowicz GM; Pecak A; Wolf S; Dubin G; Holak TA
    Cell Cycle; 2009 Apr; 8(8):1176-84. PubMed ID: 19305137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal substitution of MDM2 interacting peptides modulates binding affinity by distinctive mechanisms.
    Brown CJ; Dastidar SG; Quah ST; Lim A; Chia B; Verma CS
    PLoS One; 2011; 6(8):e24122. PubMed ID: 21904608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
    Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a novel MDM2 binding peptide based on the p53 family.
    Madhumalar A; Lee HJ; Brown CJ; Lane D; Verma C
    Cell Cycle; 2009 Sep; 8(17):2828-36. PubMed ID: 19713735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system.
    Datta S; Bucks ME; Koley D; Lim PX; Savinov SN
    Bioorg Med Chem; 2010 Aug; 18(16):6099-108. PubMed ID: 20638853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based designing efficient peptides based on p53 binding site residues to disrupt p53-MDM2/X interaction.
    Rasafar N; Barzegar A; Mehdizadeh Aghdam E
    Sci Rep; 2020 Jul; 10(1):11449. PubMed ID: 32651397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular rotors as conditionally fluorescent labels for rapid detection of biomolecular interactions.
    Goh WL; Lee MY; Joseph TL; Quah ST; Brown CJ; Verma C; Brenner S; Ghadessy FJ; Teo YN
    J Am Chem Soc; 2014 Apr; 136(17):6159-62. PubMed ID: 24494589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicomponent Peptide Stapling as a Diversity-Driven Tool for the Development of Inhibitors of Protein-Protein Interactions.
    Ricardo MG; Ali AM; Plewka J; Surmiak E; Labuzek B; Neochoritis CG; Atmaj J; Skalniak L; Zhang R; Holak TA; Groves M; Rivera DG; Dömling A
    Angew Chem Int Ed Engl; 2020 Mar; 59(13):5235-5241. PubMed ID: 31944488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel unstructured scaffold based on 4EBP1 enables the functional display of a wide range of bioactive peptides.
    See HY; Lane DP
    J Mol Biol; 2010 Dec; 404(5):819-31. PubMed ID: 20932973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.